Comparison of High-Dose Rosuvastatin Versus Low-Dose Rosuvastatin Plus Ezetimibe on Carotid Atherosclerotic Plaque Inflammation in Patients with Acute Coronary Syndrome
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Oh, Minyoung | - |
dc.contributor.author | Kim, Hyunji | - |
dc.contributor.author | Shin, Eon Woo | - |
dc.contributor.author | Sung, Changhwan | - |
dc.contributor.author | Kim, Do-Hoon | - |
dc.contributor.author | Moon, Dae Hyuk | - |
dc.contributor.author | Kim, Nayoung | - |
dc.contributor.author | Eo, Jae Seon | - |
dc.contributor.author | Kim, Jin Won | - |
dc.contributor.author | Lee, Cheol Whan | - |
dc.date.accessioned | 2021-08-30T07:07:17Z | - |
dc.date.available | 2021-08-30T07:07:17Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2020-12 | - |
dc.identifier.issn | 1937-5387 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/51353 | - |
dc.description.abstract | We compared the effects of ezetimibe/rosuvastatin 10/5 mg versus rosuvastatin 20 mg on carotid atherosclerotic plaque inflammation measured by (18)FDG PET/CT. Fifty patients with acute coronary syndrome (ACS) were randomly assigned to the ezetimibe/rosuvastatin 10/5 mg and rosuvastatin 20 mg groups. The primary outcome was the percent change in the target-to-background ratio (TBR) of the index vessel in the most diseased segment (MDS), as assessed by (18)FDG PET/CT at baseline and at 6 months. Forty-eight patients completed follow-up PET/CT. MDS TBR was - 6.2 +/- 13.9% for patients in the ezetimibe/rosuvastatin group and - 10.8 +/- 17.7% for those in the rosuvastatin group (difference, 4.6 percentage points; upper limitation of one-sided confidence interval = 13.8; p = 0.60 for noninferiority). In conclusion, combination therapy with ezetimibe 10 mg and rosuvastatin 5 mg compared with rosuvastatin 20 mg did not meet the criterion for non-inferiority for primary outcome, and the present study was not conclusive on whether the former was non-inferior to the latter. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | SPRINGER | - |
dc.subject | STATIN THERAPY | - |
dc.subject | 000 PARTICIPANTS | - |
dc.subject | CHOLESTEROL | - |
dc.subject | EFFICACY | - |
dc.subject | SAFETY | - |
dc.subject | METAANALYSIS | - |
dc.subject | INTENSITY | - |
dc.subject | ASSOCIATION | - |
dc.subject | SIMVASTATIN | - |
dc.subject | MANAGEMENT | - |
dc.title | Comparison of High-Dose Rosuvastatin Versus Low-Dose Rosuvastatin Plus Ezetimibe on Carotid Atherosclerotic Plaque Inflammation in Patients with Acute Coronary Syndrome | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Eo, Jae Seon | - |
dc.contributor.affiliatedAuthor | Kim, Jin Won | - |
dc.identifier.doi | 10.1007/s12265-020-10009-4 | - |
dc.identifier.scopusid | 2-s2.0-85085138614 | - |
dc.identifier.wosid | 000530204200005 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, v.13, no.6, pp.900 - 907 | - |
dc.relation.isPartOf | JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH | - |
dc.citation.title | JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH | - |
dc.citation.volume | 13 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 900 | - |
dc.citation.endPage | 907 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalWebOfScienceCategory | Cardiac & Cardiovascular Systems | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.subject.keywordPlus | STATIN THERAPY | - |
dc.subject.keywordPlus | 000 PARTICIPANTS | - |
dc.subject.keywordPlus | CHOLESTEROL | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordPlus | SAFETY | - |
dc.subject.keywordPlus | METAANALYSIS | - |
dc.subject.keywordPlus | INTENSITY | - |
dc.subject.keywordPlus | ASSOCIATION | - |
dc.subject.keywordPlus | SIMVASTATIN | - |
dc.subject.keywordPlus | MANAGEMENT | - |
dc.subject.keywordAuthor | Ezetimibe | - |
dc.subject.keywordAuthor | Plaque inflammation | - |
dc.subject.keywordAuthor | Statin | - |
dc.subject.keywordAuthor | Positron emission tomography | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.